1. Cancer Cell Coating Nanoparticles for Optimal Tumor-Specific Cytokine Delivery
- Author
-
Bang Nhan, Mariane B. Melo, Paula T. Hammond, Santiago Correa, Cathy Nguyen, Sean G. Smith, Darrell J. Irvine, Antonio E. Barberio, Heikyung Suh, and Talar Tokatlian
- Subjects
medicine.medical_treatment ,Cell ,General Physics and Astronomy ,02 engineering and technology ,010402 general chemistry ,01 natural sciences ,Article ,Immune system ,Drug Delivery Systems ,Neoplasms ,medicine ,Humans ,General Materials Science ,Cytokine Therapy ,business.industry ,General Engineering ,021001 nanoscience & nanotechnology ,0104 chemical sciences ,medicine.anatomical_structure ,Cytokine ,Toxicity ,Cancer cell ,Drug delivery ,Cancer research ,Nanomedicine ,Cytokines ,Nanoparticles ,0210 nano-technology ,business - Abstract
© 2020 American Chemical Society. Although cytokine therapy is an attractive strategy to build a more robust immune response in tumors, cytokines have faced clinical failures due to toxicity. In particular, interleukin-12 has shown great clinical promise but was limited in translation because of systemic toxicity. In this study, we demonstrate an enhanced ability to reduce toxicity without affecting the efficacy of IL-12 therapy. We engineer the material properties of a NP to meet the enhanced demands for optimal cytokine delivery by using the layer-by-layer (LbL) approach. Importantly, using LbL, we demonstrate cell-level trafficking of NPs to preferentially localize to the cell's outer surface and act as a drug depot, which is required for optimal payload activity on neighboring cytokine membrane receptors. LbL-NPs showed efficacy against a tumor challenge in both colorectal and ovarian tumors at doses that were not tolerated when administered carrier-free.
- Published
- 2020